Cargando…

The Critical Role of Pharmacists in the Clinical Delivery of Pharmacogenetics in the U.S

Since the rebirth of pharmacogenomics (PGx) in the 1990s and 2000s, with new discoveries of genetic variation underlying adverse drug response and new analytical technologies such as sequencing and microarrays, there has been much interest in the clinical application of PGx testing. The early involv...

Descripción completa

Detalles Bibliográficos
Autor principal: Haga, Susanne B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10514841/
https://www.ncbi.nlm.nih.gov/pubmed/37736916
http://dx.doi.org/10.3390/pharmacy11050144
_version_ 1785108813749157888
author Haga, Susanne B.
author_facet Haga, Susanne B.
author_sort Haga, Susanne B.
collection PubMed
description Since the rebirth of pharmacogenomics (PGx) in the 1990s and 2000s, with new discoveries of genetic variation underlying adverse drug response and new analytical technologies such as sequencing and microarrays, there has been much interest in the clinical application of PGx testing. The early involvement of pharmacists in clinical studies and the establishment of organizations to support the dissemination of information about PGx variants have naturally resulted in leaders in clinical implementation. This paper presents an overview of the evolving role of pharmacists, and discusses potential challenges and future paths, primarily focused in the U.S. Pharmacists have positioned themselves as leaders in clinical PGx testing, and will prepare the next generation to utilize PGx testing in their scope of practice.
format Online
Article
Text
id pubmed-10514841
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-105148412023-09-23 The Critical Role of Pharmacists in the Clinical Delivery of Pharmacogenetics in the U.S Haga, Susanne B. Pharmacy (Basel) Review Since the rebirth of pharmacogenomics (PGx) in the 1990s and 2000s, with new discoveries of genetic variation underlying adverse drug response and new analytical technologies such as sequencing and microarrays, there has been much interest in the clinical application of PGx testing. The early involvement of pharmacists in clinical studies and the establishment of organizations to support the dissemination of information about PGx variants have naturally resulted in leaders in clinical implementation. This paper presents an overview of the evolving role of pharmacists, and discusses potential challenges and future paths, primarily focused in the U.S. Pharmacists have positioned themselves as leaders in clinical PGx testing, and will prepare the next generation to utilize PGx testing in their scope of practice. MDPI 2023-09-10 /pmc/articles/PMC10514841/ /pubmed/37736916 http://dx.doi.org/10.3390/pharmacy11050144 Text en © 2023 by the author. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Haga, Susanne B.
The Critical Role of Pharmacists in the Clinical Delivery of Pharmacogenetics in the U.S
title The Critical Role of Pharmacists in the Clinical Delivery of Pharmacogenetics in the U.S
title_full The Critical Role of Pharmacists in the Clinical Delivery of Pharmacogenetics in the U.S
title_fullStr The Critical Role of Pharmacists in the Clinical Delivery of Pharmacogenetics in the U.S
title_full_unstemmed The Critical Role of Pharmacists in the Clinical Delivery of Pharmacogenetics in the U.S
title_short The Critical Role of Pharmacists in the Clinical Delivery of Pharmacogenetics in the U.S
title_sort critical role of pharmacists in the clinical delivery of pharmacogenetics in the u.s
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10514841/
https://www.ncbi.nlm.nih.gov/pubmed/37736916
http://dx.doi.org/10.3390/pharmacy11050144
work_keys_str_mv AT hagasusanneb thecriticalroleofpharmacistsintheclinicaldeliveryofpharmacogeneticsintheus
AT hagasusanneb criticalroleofpharmacistsintheclinicaldeliveryofpharmacogeneticsintheus